NCAPH2 and cancer: These analysis methods can be used to quantitatively describe changes in centromere distribution in response to a specific experimental perturbation, for example, loss of the cohesin component NCAPH2 as shown here, or during physiological or pathological processes such as differentiation, development and in disease such as cancer.